losartan has been researched along with Aortitis Syndrome in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Excerpt | Relevance | Reference |
---|---|---|
"Prognosis in Takayasu's arteritis is limited owing to renovascular hypertension." | 1.31 | Enalapril and losartan augment endogenous nitric oxide release in Takayasu's arteritis--a case report. ( Baldamus, CA; Marsen, TA; Pollok, M; Sukau, G, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Marsen, TA | 1 |
Sukau, G | 1 |
Pollok, M | 1 |
Baldamus, CA | 1 |
1 other study available for losartan and Aortitis Syndrome
Article | Year |
---|---|
Enalapril and losartan augment endogenous nitric oxide release in Takayasu's arteritis--a case report.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Enalapril; Endothelin-1; Female; | 2000 |